SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-015732
Filing Date
2022-06-02
Accepted
2022-06-02 16:30:47
Documents
14
Period of Report
2021-01-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 65634
2 ex99-1.htm EX-99.1 176179
  Complete submission text file 0001493152-22-015732.txt   509028

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT foxwu-20210122.xsd EX-101.SCH 4150
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT foxwu-20210122_def.xml EX-101.DEF 27514
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT foxwu-20210122_lab.xml EX-101.LAB 38029
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT foxwu-20210122_pre.xml EX-101.PRE 26132
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 7172
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39891 | Film No.: 22991255
SIC: 2834 Pharmaceutical Preparations